Philip Morris Products S.A.
Clinical trials sponsored by Philip Morris Products S.A., explained in plain language.
Tobacco company developing and selling reduced-risk nicotine products.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
-
Heated tobacco vs cigarettes: which is less harmful?
Knowledge-focused CompletedThis study looked at whether people who used a tobacco heating system for at least 2 years had lower levels of harmful chemicals, cell stress, and inflammation in their bodies compared to cigarette smokers. About 974 healthy adults aged 30-60 from Asia and Europe took part. The g…
Sponsor: Philip Morris Products S.A. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Nicotine tablets put focus to the test: small study explores attention boost
Knowledge-focused CompletedThis study looked at how nicotine from dissolvable tablets affects attention in 40 adults who occasionally use nicotine pouches. Participants tried tablets with different nicotine amounts (0 to 2 mg) and took attention tests after 15 minutes and 2 hours. The goal was to understan…
Sponsor: Philip Morris Products S.A. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Tobacco-Free nicotine stick put to the test against cigarettes
Knowledge-focused CompletedThis study involved 24 adult smokers who used three different nicotine products: a tobacco-free nicotine stick, a heated tobacco stick, and regular cigarettes. Researchers measured how much nicotine entered the blood and how the body processed it. The goal was to understand the d…
Sponsor: Philip Morris Products S.A. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC